NICE guidance recommends formal assessment at six months, with continuation criteria including HbA1c reduction of at least 11 mmol/mol and weight loss of at least 3% where applicable
A retrospective analysis of the FDAs Adverse Event Reporting System (FAERS) identified disproportionality signals for semaglutide in both depression (reporting odds ratio [ROR]: 1.87
Clinical data suggests tirzepatide produces slightly more weight loss on average, but semaglutide is less expensive and has a longer track record
The study also included a catalytically inactive C145A M pro mutant (lacking the active site cysteine), which was also used as a bait protein, in order to discriminate false positives that might bind non-specifically to the M pro active site cysteine via disulfide bond formation
Blood tests, hormone checks, and tracking changes over time may all be part of the evaluation
TB-500, a synthetic derivative of thymosin 4, promotes progenitor cell differentiation and angiogenesis, supporting vascular growth and tissue repair